Skip to main content
Global
Global Fin Swe Nor Den Ger Cze Svk Pol Nld Bel (nl) Bel (fr) USA
Log in
  • Aidian – Your aid in diagnostics
  • Point-of-care testing
  • Products
  • About us
  • Insights hub
  • Antimicrobial resistance
  • Events
  • For distributors / Log in
Contact us Search
Logo
Contact us
  • Point of care
  • Microbiology
  • Hygiene monitoring
  • Molecular diagnostics
  • RIA / Collagens
  • Products available in the USA
Point of care
  • QuikRead go system
  • QuikRead 101
Read more
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go accessories
QuikRead go
Microbiology
  • Uricult
  • Uricult Vet
  • Cultura M
Read more
Hygiene monitoring
  • Easicult
  • Hygicult
  • Cultura M
  • Clean Card PRO
Read more
NEW! A comprehensive guide to monitoring surface hygiene now updated
Read more
Molecular diagnostics
  • SIBA
Read more
SIBA licensing and partnering opportunities
Read more
RIA / Collagens
  • UniQ
Read more
  • Our history
  • Board and management
  • Values and culture
  • Sustainability
  • Careers
  • Employee stories
  • Partnering and licensing
  • UN Global Compact Commitment
  • Aidian logos
  • Health topics
  • Highlights
  • About C-reactive protein (CRP)
  • A guide to monitoring surface hygiene
  • Customer stories
  • News
  • AMR interview
  • Spreading of antibiotic resistant bacteria
  • Educational materials
  • Useful links
Modify Selected Code…
Contact us Close
  • Point-of-care testing
  • Products
    • Point of care
      • QuikRead go system
      • QuikRead 101
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Cultura M
      • Clean Card PRO
    • Molecular diagnostics
      • SIBA
    • RIA / Collagens
      • UniQ
    • Products available in the USA
  • About us
    • Our history
    • Board and management
    • Values and culture
    • Sustainability
    • Careers
    • Employee stories
    • Partnering and licensing
    • UN Global Compact Commitment
    • Aidian logos
  • Insights hub
    • Health topics
      • Respiratory tract infections
    • Highlights
    • About C-reactive protein (CRP)
    • A guide to monitoring surface hygiene
    • Customer stories
    • News
  • Antimicrobial resistance
    • AMR interview
    • Spreading of antibiotic resistant bacteria
    • Educational materials
    • Useful links
  • Events
  • For distributors / Log in
Popular products
QuikRead go Plus Instrument

QuikRead go Plus Instrument

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news
View all

Meet us at WONCA Europe Conference 2026

3 June 2026 | News, Events

Welcome Torben Nielsen, our new CEO

2 June 2026 | News

Preparing for tick season with reliable diagnostics

27 May 2026 | News, Product news

  • View all
  • No results found
  • Loading...
News

Meet us at WONCA Europe Conference 2026

3 June 2026 | News, Events

Welcome Torben Nielsen, our new CEO

2 June 2026 | News

Back to all news
22 October 2020

CRP is one of the predicting factors related to to COVID-19 disease severity

CRP is one of the predicting factors related to to COVID-19 disease severity. An online calculator for predicting in-hospital course of COVID-19 infection from Johns Hopkins University, US – CRP included.
 

An online calculator for predicting severity of COVID-19 infection has been developed in Johns Hopkins University in the US. Using the data available on admission, the model predicts in-hospital COVID-19 progression to severe disease or death¹. The predictive accuracy of outcome was best for the first 2 days of hospital admission but provided useful estimations for days 4 and 7 as well. CRP concentration is one of the predicting factors as it is easily available and has shown to be significantly related to COVID-19 disease severity.² ³

The COVID-19 Inpatient Risk Calculator (CIRC) is based on the multicenter study of consecutive 832 patients in five hospitals in the Maryland and Washington, DC area (US) that comprise the Johns Hopkins Medicine (JHM) health care system. Early identification of patients that will develop severe disease is important for right clinical decisions and resource allocation.² Especially now that the second wave of COVID-19 is upon us, there is a need to have prediction models for efficient usage of ICU resources and for saving lives. How does this model work in different territories?

Find the calculator and the publication below:

https://rsconnect.biostat.jhsph.edu/covid_predict/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530643/pdf/aim-olf-M203905.pdf

References:

  1. https://rsconnect.biostat.jhsph.edu/covid_predict/
  2. Garibaldi BT, Fiksel J, Muschelli J et al. Patient Trajectories Among Persons Hospitalized for COVID-19. A Cohort Study. 2020 Ann Intern Med. 2020 doi:10.7326/M20-3905
  3. Zhang ZL, Hou YL, Li DT, Li FZ. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Invest. 2020, doi: 10.1080/00365513.2020.1768587
Share
Facebook
Twitter
Email

Aidian Oy

Koivu-Mankkaan tie 6 B
FI-02200 Espoo Finland
P.O. Box 83
FI-02101 Espoo Finland

 

+358 10 309 3000

Company
  • About us
  • Careers
  • Contact us
  • Events
  • Product-specific inquiries
  • Sales support
  • Sales related inquiries
  • Sustainability
Products
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
Quick links
  • Aidian Academy
  • Aidian Connect
  • Insights hub
  • IFU Revision histories
Copyright © 2026 Aidian
  • Privacy
  • Privacy Statements
  • Cookie Policy
  • Social Media Policy